Artificial Intelligence in Diabetes Management Market Size Expansion: Projected to Hit $2.56 Billion by 2029 with 33.7% Growth

 The Business Research Company’s report on the Artificial Intelligence in Diabetes Management Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.

 
 What are the primary drivers fueling the growth of the artificial intelligence in diabetes management market in recent years?
 The rising prevalence of diabetes is expected to propel artificial intelligence in the diabetes management market going forward. Diabetes occurs when the blood glucose, or blood sugar, is too high. Diabetes is a condition that causes various conditions such as eye problems, heart attacks and strokes, kidney problems, and others. Artificial intelligence is used to manage diabetes as it provides information about high or low blood sugar levels in a diabetic patient and collects data that has not been used previously. For instance, in June 2024, according to National Health Service (NHS England), a UK-based publicly funded healthcare system, 3,615,330 people registered with a GP were found to have non-diabetic hyperglycaemia — also known as pre-diabetes -in 2023, compared to 3,065,825 in 2022 — an increase of almost a fifth (18%). Therefore, the rising prevalence of diabetes is driving the growth of artificial intelligence in the diabetes management market.
 
 Access Your Free Sample of the Global Artificial Intelligence in Diabetes Management Market Report — Get Insights Now!
 https://www.thebusinessresearchcompany.com/sample.aspx?id=12593&type=smp
 
 What is the projected market size of the artificial intelligence in diabetes management industry, and how is it expected to grow?
 The artificial intelligence in diabetes management market size has grown exponentially in recent years. It will grow from $0.62 billion in 2024 to $0.8 billion in 2025 at a compound annual growth rate (CAGR) of 30.2%. The growth in the historic period can be attributed to data accumulation, rising diabetes cases, healthcare cost pressures, early ai applications
 
 The artificial intelligence in diabetes management market size is expected to see exponential growth in the next few years. It will grow to $2.56 billion in 2029 at a compound annual growth rate (CAGR) of 33.7%. The growth in the forecast period can be attributed to ai-powered decision support systems, telemedicine integration, genomic data utilization, regulatory support. Major trends in the forecast period include advancements in wearable technology, personalized treatment plans, continuous glucose monitoring advances, ai-powered risk prediction, behavioral modification support.
 
 Gain Exclusive Market Insights — Customize Your Research Report Today For Fast Delivery!
 https://www.thebusinessresearchcompany.com/customise?id=12593&type=smp
 
 Who are the key players driving competition in the artificial intelligence in diabetes management market?
 Major companies operating in the artificial intelligence in diabetes management market include Alphabet Inc., F. Hoffmann-La Roche AG, Abbott Laboratories, Medtronic Plc, Dexcom Inc., Insulet Corporation, Tandem Diabetes Care Inc., LifePlus Inc., Livongo Health Inc., Xeris Pharmaceuticals Inc., Virta Health Corp., Informed Data Systems Inc., Bigfoot Biomedical Inc., Lark Technologies Inc., Smart Meter LLC, Diabeloop SA, Quin Technology Ltd., Wellthy Therapeutics Pvt Ltd., Admetsys LLC, DreaMed Diabetes Ltd., Eyenuk Inc., Glooko Inc., PKvitality, Glytec LLC, Hygieia Inc., TypeZero Technologies Inc., Nemaura Medical Inc., GlucoMe, PredictBGL, Voluntis S.A.
 
 What key trends are expected to drive the artificial intelligence in cardiology market during the forecast period?
 Technological advancements are a key trend gaining popularity in the artificial intelligence in diabetes management market. Major companies operating in the artificial intelligence in diabetes management market are focused on innovating new and advanced technological solutions to sustain their position in the market. For instance, in October 2022, Dr. Mohan’s Diabetes Specialties Center, an India-based diabetes specialty hospital chain, launched an innovative artificial intelligence-enabled platform for precision diabetes care with the 3D Initiative. The first of the three Ds is DIA, an AI-powered chatbot that can help individuals through pre-recorded digital interactions. The second is DIALA, a user-friendly smartphone app for patients; the last is DIANA, a medical app for precise diabetic care. According to the company, it is supported by the most advanced Total Experience (TX) Automation Platform, which powers an AI-enabled virtual assistant that interacts with patients on platforms such as Facebook Messenger, WhatsApp, Google Business Message, and the web.
 
 Which key geographies are driving the growth of the artificial intelligence in diabetes management market?
 North America was the largest region in the artificial intelligence (AI) in diabetes management market in 2024. The regions covered in the artificial intelligence in diabetes management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
 
 Order Your Report Now For Swift Delivery
 https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-diabetes-management-global-market-report
 
 What are the key segments driving growth in the artificial intelligence in diabetes management market?
 The artificial intelligence in diabetes management market covered in this report is segmented –
 
 1) By Device: Diagnostic Devices, Glucose Monitoring Devices, Insulin Delivery Devices, Other Devices
 2) By Techniques: Case-Based Reasoning, Intelligent Data Analysis
 3) By End-Use: Hospitals, Clinics, Home Care Settings, Research Institutes
 
 Subsegments:
 1) By Diagnostic Devices: Blood Glucose Meters, Continuous Glucose Monitors (CGMs), A1C Testing Devices, Urine Testing Devices
 2) By Glucose Monitoring Devices: Continuous Glucose Monitors (CGMs), Flash Glucose Monitoring Systems, Smart Glucose Meters
 3) By Insulin Delivery Devices: Insulin Pens, Insulin Pumps, Insulin Jet Injectors, Smart Insulin Delivery Systems
 4) By Other Devices: Diabetes Management Apps, Wearable Devices, Smart Health Monitors, Insulin Refrigerators
 
 Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
 https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12593
 
 What defines the structure and scope of the artificial intelligence in diabetes management market?
 Artificial intelligence in diabetes management refers to using AI technologies and algorithms to spot patterns in behavior that lead to either high or low blood sugar levels in diabetes patients. Artificial intelligence in diabetes management improves various aspects of diabetes care, including decision support, prediction, lifestyle guidance, and treatment management.
 
 About The Business Research Company:
 
 With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead. 
 
 Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
 
 Contact Us:
 
 The Business Research Company
 
 https://thebusinessresearchcompany.com/
 
 Europe: +44 207 1930 708
 
 Asia: +91 88972 63534
 
 Americas: +1 315 623 0293
 
 Email: info@tbrc.info
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company